
What happens to kidney care when Medicare’s CKCC model sunsets and LEAD begins?
APC CEO Scott Brunner, CAE, discusses compounding drugs, including the GLP-1 RA antidiabetes and antiobesity medications.
There are three criteria for compounding pharmacists to mix a version of a medicine that is not available from a




